Shkreli’s actions reveal larger Pharma issues: Your Say

Martin Shkreli resigned as CEO of Turing Pharmaceuticals after his recent arrest in connection with an alleged Ponzi scheme. Shkreli made headlines earlier this year after raising the price of a life-saving drug 5,000%.

Facebook comments edited for clarity and grammar:

Sometimes the system works. This guy was greedy and arrogant. I hope the U.S. attorney throws the book at him.

—Jack Climer

Sadly, Shkreli’s behavior as a drug company CEO isn’t unheard of for big pharmaceutical companies. Cancer drugs that cost more than the median income per year are becoming the rule. Drugs increase in price by double figures on an almost yearly basis. The drug Gleevec cost about $30,000 per year in 2001. Now its price has more than tripled. Has your salary tripled? Drug companies are unscrupulous and manipulative. They have Congress on their payroll, so little is likely to change.

—Paul Goff

This young man is willing to force a family into bankruptcy or force them to let a family member die. Are we surprised that he is accused of breaking the law?

Parents: Character education is important. Teach your children to be ethical adults so we can rid the world of people like Shkreli.

—Tyler James Austenfeld